跳到正文
原文
HHS· @HHSGov · X·· 4 天前AI 评分38
AI 导读

HHS与ARPA-H宣布新资助,推进退伍军人及平民精神健康治疗研发,其中近500万美元用于伊博格碱(ibogaine)作为潜在PTSD治疗,2000万美元支持速效精神类药物干预研究。肯尼迪部长与CMS、FDA、ARPA-H、NIMH及退伍军人事务部代表共同出席发布会。

正文

Yesterday, @SecKennedy made announcements on new HHS and @ARPA_H funding that will advance the development of mental health treatments for veterans and civilians including an almost $5 million in ibogaine as a potential PTSD treatment, and $20 million to support research on rapid-acting psychotropics interventional drugs.

Joining Secretary Kennedy for the press conference were @DrOzCMS, @FDA_KyleD, Chief Medical Officer for ARPA-H Dr. Rafid Fadul, Acting Director of the National Institute of Mental Health Dr. Andrea Beckel-Mitchener, and @DeptVetAffairs Senior Advisor Andrew Gradison.

来源:HHS · x.com